🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
7.04
-0.20 (-2.76%)
At close: Nov 20, 2026, 4:00 PM EST
7.03
-0.01 (-0.14%)
After-hours: Nov 20, 2026, 7:30 PM EST

Evommune Statistics

Total Valuation

Evommune has a market cap or net worth of $291.10 million. The enterprise value is $130.66 million.

Market Cap291.10M
Enterprise Value 130.66M

Important Dates

The last earnings date was Thursday, November 12, 2026, after market close.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

Evommune has 41.35 million shares outstanding. The number of shares has increased by 1,950.51% in one year.

Current Share Class 41.35M
Shares Outstanding 41.35M
Shares Change (YoY) +1,950.51%
Shares Change (QoQ) +0.53%
Owned by Insiders (%) 2.20%
Owned by Institutions (%) 51.83%
Float 24.42M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 465.76
PB Ratio 1.02
P/TBV Ratio 1.16
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 8.52, with a Debt / Equity ratio of 0.03.

Current Ratio 8.52
Quick Ratio 8.33
Debt / Equity 0.03
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -69.53% and return on invested capital (ROIC) is -45.59%.

Return on Equity (ROE) -69.53%
Return on Assets (ROA) -41.99%
Return on Invested Capital (ROIC) -45.59%
Return on Capital Employed (ROCE) -47.28%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$2.36M
Employee Count 48
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -63.50% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -63.50%
50-Day Moving Average 7.13
200-Day Moving Average 16.87
Relative Strength Index (RSI) 50.10
Average Volume (20 Days) 1,041,197

Short Selling Information

The latest short interest is 3.39 million, so 8.19% of the outstanding shares have been sold short.

Short Interest 3.39M
Short Previous Month 2.89M
Short % of Shares Out 8.19%
Short % of Float 13.87%
Short Ratio (days to cover) 3.16

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -121.89M
Pretax Income -113.07M
Net Income -113.07M
EBITDA -120.13M
EBIT -121.89M
Earnings Per Share (EPS) -$3.59
Full Income Statement

Balance Sheet

The company has $168.64 million in cash and $8.19 million in debt, with a net cash position of $160.45 million or $3.88 per share.

Cash & Cash Equivalents 168.64M
Total Debt 8.19M
Net Cash 160.45M
Net Cash Per Share $3.88
Equity (Book Value) 251.37M
Book Value Per Share 6.91
Working Capital 154.08M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$90.40 million and capital expenditures -$603,000, giving a free cash flow of -$91.00 million.

Operating Cash Flow -90.40M
Capital Expenditures -603,000
Depreciation & Amortization 1.77M
Net Borrowing -456,000
Free Cash Flow -91.00M
FCF Per Share -$2.20
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Evommune does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -1,950.51%
Shareholder Yield -1,950.51%
Earnings Yield -50.95%
FCF Yield -31.26%

Analyst Forecast

The average price target for Evommune is $21.89, which is 210.94% higher than the current price. The consensus rating is "Buy".

Price Target $21.89
Price Target Difference 210.94%
Analyst Consensus Buy
Analyst Count 12
Revenue Growth Forecast (3Y) -52.42%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Evommune has an Altman Z-Score of 12.23 and a Piotroski F-Score of 2.

Altman Z-Score 12.23
Piotroski F-Score 2